Zhao RY, Li HH, Zhang KC, Cui H, Deng H, Gao JW, Wei B. Comparison of short-term efficacy between totally laparoscopic gastrectomy and laparoscopic assisted gastrectomy for elderly patients with gastric cancer. World J Gastrointest Surg 2022; 14(9): 950-962 [PMID: 36185561 DOI: 10.4240/wjgs.v14.i9.950]
Corresponding Author of This Article
Bo Wei, MD, PhD, Chief Doctor, Department of General Surgery, First Medical Center, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing 100853, China. weibo@301hospital.com.cn
Research Domain of This Article
Surgery
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Surg. Sep 27, 2022; 14(9): 950-962 Published online Sep 27, 2022. doi: 10.4240/wjgs.v14.i9.950
Table 1 Clinical and pathological characteristics of laparoscopic assisted gastrectomy and totally laparoscopic gastrectomy group for elderly patients (mean ± SD)
Characteristics
LAG group (n = 232)
TLG group (n = 230)
P value
Gender
0.472
Male
183
175
Female
49
55
Age (yr)
74.62 ± 3.80
74.69 ± 4.10
0.848
BMI (kg/m2)
23.31 ± 3.08
23.64 ± 3.46
0.285
aCCI score, n (%)
0.608
0-4
188
182
> 4
44
48
ASA score, n (%)
0.426
I
1
1
II
177
168
III
54
61
History of abdominal surgery
0.232
No
189
177
Yes
43
53
Tumor resection
0.163
Distal
125
109
Total
107
121
Neoadjuvant chemotherapy
0.201
No
223
215
Yes
9
15
Tumor diameters (cm) (median, IQR)
4.00 (2.58-6.00)
4.00 (2.65-5.5)
0.230
pT
0.895
T0
2
0
T1
38
43
T2
36
37
T3
116
107
T4
40
43
pN
0.544
N0
83
77
N1
33
33
N2
49
48
N3
67
72
pTNM
0.857
0
2
0
I
52
60
II
65
57
III
113
113
Nerve invasion
0.249
Yes
71
82
No
161
148
Vascular invasion
0.685
Yes
91
86
No
141
144
Differentiation
0.945
Well/moderate
151
149
Poor/undifferentiated
81
81
Table 2 Perioperative outcomes between laparoscopic assisted gastrectomy and totally laparoscopic gastrectomy group for elderly patients (mean ± SD)
Variable
LAG group (n = 232)
TLG group (n = 230)
P value
Surgical time, min
221.34 ± 54.96
216.48 ± 52.53
0.332
Blood loss, ml (median, IQR)
100.0 (50.0-200.0)
100.0 (50.0-100.0)
0.000
Anastomotic approach
B1
17
14
B2 (+Braun)
39
36
Roux-en-Y
176
180
Retrieved lymph nodes, n
29.32 ± 11.27
30.69 ± 12.65
0.218
Extent of resection
R0
218
215
R1/R2
14
15
Time to first flatus, d
4.43 ± 1.20
3.79 ± 1.15
0.000
Postoperative day, d (median, IQR)
8.0 (7.0-10.0)
7.75 (6.0-9.0)
0.000
Total complication rate (%)
61 (26.3)
38 (16.5)
0.010
Anastomotic-related complication rate (%)
8 (3.4)
6 (2.6)
0.599
Clavien-Dindo classification
Grade II
Deep venous thrombosis
1
1
Lymphatic leakage
1
0
Gastroplegia
1
2
Anaphylaxis
1
1
Ileus
0
1
Cardiac failure
1
0
Hypoproteinemia
10
7
Anemia
12
7
Cholecystitis
2
0
Incision infection
2
1
Atrial fibrillation
4
2
Pneumonia
8
2
Anastomotic leakage
5
2
Anastomotic bleeding
0
2
Anastomotic stenosis
1
0
Duodenal trump leakage
2
1
Grade IIIa
Deep venous thrombosis
0
0
Pleural effusion
4
3
Anastomotic leakage
2
2
Duodenal trump leakage
1
1
Abdominal bleeding
0
1
Grade IV
Cardiac failure
2
0
Abdominal bleeding
1
1
Acute cerebral infarction
0
1
Severe complication rate (%)
10 (4.3)
9 (3.9)
0.830
Table 3 Uni- and multivariate analysis of postoperative complications for elderly patients
Factor
Univariate analysis
P value
Multivariate analysis
P value
OR
95%CI
OR
95%CI
Sex
0.462
Male
1.000
Female
1.215
0.724-2.038
Age (yr)
0.027
0.157
< 75
1.000
1.000
≥ 75
1.655
1.058-2.587
1.422
0.874-2.313
BMI (kg/m2)
0.321
< 25
1.000
≥ 25
0.779
0.475-1.276
Surgical approach
0.011
0.011
LAG
1.000
1.000
TLG
0.555
0.352-0.874
0.539
0.335-0.865
aCCI score
0.074
0.416
0-4
1.000
1.000
> 4
1.603
0.952-2.699
1.276
0.709-2.294
ASA score
0.030
0.069
≤ II
1.000
1.000
> II
1.713
1.055-2.783
1.626
0.963-2.744
Tumor resection
0.846
Distal
1.000
Total
0.957
0.613-1.493
Neoadjuvant chemotherapy
0.752
No
1.000
Yes
1.165
0.452-3.000
pTNM stage
0.918
0-I
1.000
II
1.072
0.571-2.012
III
1.124
0.645-1.958
Tumor diameter (cm)
0.020
0.116
≤ 3
1.000
1.000
> 3
1.815
1.101-2.995
1.535
0.900-2.618
Operation time (min)
0.031
0.039
≤ 220
1.000
1.000
> 220
1.636
1.047-2.558
1.671
1.027-2.718
Estimated blood loss (mL)
0.120
0.895
≤ 200
1.000
1.000
> 200
1.628
0.880-3.012
1.047
0.530-2.070
Vascular invasion
0.035
0.223
No
1.000
1.000
Yes
1.620
1.034-2.538
1.349
0.834-2.185
Nerve invasion
0.667
No
1.000
Yes
0.901
0.559-1.451
Differentiation
0.760
Well/moderate
1.000
Poor/undifferentiated
1.075
0.676-1.708
R0 resection
0.197
0.263
No
1.000
1.000
Yes
1.715
0.755-3.895
1.639
0.690-3.892
Table 4 Quality of life using European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire and STO-22 questionnaire between laparoscopic assisted gastrectomy and totally laparoscopic gastrectomy group
Factor
Baseline
P value
Postoperative 3 mo
P value
LAG group
TLG group
LAG group
TLG group
QLQ-C30 questionnaire
Global status
91.6 (91.6-100)
91.6 (91.6-100)
0.096
91.6 (91.6-100)
91.6 (91.6-100)
0.934
Physical functioning
100 (93.3-100)
100 (93.3-100)
0.863
100 (93.3-100)
96.7(93.3-100)
0.777
Role functioning
100 (83.3-100)
100 (83.3-100)
0.269
100 (83.3-100)
83.3 (83.3-100)
0.804
Emotional functioning
91.6 (91.6-100)
91.6 (91.6-100)
0.343
91.6 (91.6-100)
91.6 (91.6-100)
0.880
Cognitive functioning
100 (83.3-100)
100 (83.3-100)
0.962
100 (83.3-100)
100 (83.3-100)
0.925
Social functioning
100 (83.3-100)
100 (83.3-100)
0.853
100 (83.3-100)
100 (83.3-100)
0.925
Fatigue
0 (0-0)
0 (0-0)
0.471
0 (0-0)
0 (0-11)
0.170
Nausea and vomiting
0 (0-0)
0 (0-0)
0.133
0 (0-12.5)
0 (0-0)
0.043
Pain
0 (0-0)
0 (0-0)
0.507
0 (0-0)
0 (0-0)
0.772
Dyspnea
0 (0-0)
0 (0-0)
0.165
0 (0-0)
0 (0-0)
0.880
Insomnia
0 (0-33.3)
0 (0-33.3)
0.428
0 (0-33.3)
0 (0-33.3)
0.984
Appetite loss
0 (0-0)
0 (0-33.3)
0.494
0 (0-33.3)
0 (0-33.3)
0.899
Constipation
0 (0-33.3)
0 (0-33.3)
0.529
33.3 (0-33.3)
0 (0-33.3)
0.024
Diarrhea
0 (0-0)
0 (0-0)
0.122
0 (0-0)
0 (0-0)
0.705
Financial difficulties
0 (0-33.3)
0 (0-33.3)
0.081
0 (0-33.3)
0 (0-33.3)
0.355
STO-22 questionnaire
Dysphagia
0 (0-0)
0 (0-0)
0.547
0 (0-22)
0 (0-11)
0.169
Pain
0 (0-0)
0 (0-0)
0.793
0 (0-14.6)
0 (0-8.3)
0.389
Reflux
0 (0-11)
0 (0-11)
0.444
0 (0-22)
0 (0-22)
0.548
Eating restrictions
0 (0-0)
0 (0-0)
0.441
0 (0-8.3)
0 (0-8.3)
0.848
Anxiety
0 (0-11)
0 (0-11)
0.952
0 (0-22)
0 (0-22)
0.214
Dry mouth
0 (0-0)
0 (0-0)
0.681
0 (0-0)
0 (0-0)
0.982
Taste
0 (0-0)
0 (0-0)
0.609
0 (0-0)
0 (0-0)
0.858
Body image
0 (0-0)
0 (0-0)
0.573
0 (0-33.3)
0 (0-0)
0.000
Hair loss
0 (0-0)
0 (0-0)
0.442
0 (0-0)
0 (0-0)
0.077
Citation: Zhao RY, Li HH, Zhang KC, Cui H, Deng H, Gao JW, Wei B. Comparison of short-term efficacy between totally laparoscopic gastrectomy and laparoscopic assisted gastrectomy for elderly patients with gastric cancer. World J Gastrointest Surg 2022; 14(9): 950-962